>> Tuesday, June 23, 2009
The Zicam news from last week has now been reported in virtually every channel imaginable. Anyone in the marketing space knows the scoop. So I wasn't going to comment on it because honestly I didn't think I had anything to add to the story.
But I got to thinkin' ...
I hope that this recent news doesn't become a "Zicam effect" on product innovation. Yes, products should be tested for both their efficacy and their safety. And yes, the FDA should govern over both the practices to prove efficacy/safety as well as manufacturer compliance.
But as a health and wellness industry, we need to continue to innovate. We need to continually come up with new solutions that help consumers stay well. We need to give them options and choices, using the latest in science and technology and imagination.
When Zicam was first introduced, I was working on Tylenol. As someone who was working in the cough/cold/flu category for over a decade, I was so impressed by the innovation. Zicam was a new option for consumers and it quickly became a success.
No we shouldn't put products in the market that can cause damage, and I don't personally know if that's even the case with Zicam. I don't know enough about the situation. But I also don't want to have the industry get scared into submission, and pull back on product development and innovation as a result.
That would be a bad effect of the recent Zicam news. Let's keep innovating -- and testing our imagination.
Hope this finds you well -- Jim.